课题基金 / 基金详情

1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education

1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
1/2:UHCOP-DLDCCC 联盟:癌症药物发现/开发和教育
批准号:
9789213
负责人:
Jason Yustein
金额:
$3.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Jason Yustein的其他基金

相似基金

相关文献

中文摘要
翻译
! 项目概要(CREP) 合作癌症研究教育计划(CREP)的总体目标, 休斯顿(UH)和NCI指定的丹L。贝勒邓肯综合癌症中心(DLDCCC) 医学院(ESTA)是鼓励和准备代表性不足(UR)的本科生和研究生 学生进入癌症研究的职业生涯。我们建议提供癌症研究经验, 新的癌症特定课程,并通过独立的,但 互补的目标。虽然整体P20合作将是药学院(UHCOP)之间的呃 和DLDCCC,合作CREP将从事本科生在呃和研究生 进行癌症研究。首先,我们会加强香港的癌症研究经验, 本科生和研究生。这将通过(1)为UH本科生提供 在UH和DLDCCC的癌症药物发现和开发领域的研究经验,(2) 以跨机构的方式和通过论文共享成员的方式提供使用核心研究设施的机会 委员会,以增加研究能力和研究生在呃和DLDCCC曝光, 以及(3)利用国家研究指导网络开发的myNRMN和指导模块 (NRMN),以有效地解决研究指导中的文化多样性问题 关系。第二,我们将为本科生和研究生开发新的癌症研究课程和方法。 研究生。在这里,我们将开发一个关于癌症研究的多学科研讨会系列,以揭露UH 本科生到癌症研究的多个领域和一个新的联合课程"新兴技术" 在癌症药物发现/开发",这将大大有助于现有的课程研究生 学生在UH和DLDCCC/ESTA。第三,我们将为认识癌症的文化多样性健康差异做好准备 研究人员这将通过加强UR学生获得指导和职业发展来实现 活动,如新创建的"与癌症研究人员共进午餐"系列, 研究人员在他们的职业生涯的各个阶段,为本科生的GRE预科课程,和专业 为研究生举办赠款/研究金发展讲习班。使人们更多了解 癌症健康差距,我们还将在DLDCCC推出一个新的癌症健康差距系列研讨会 并通过参与剧院外展活动为CREP参与者提供社区外展机会 该方案由DLDCCC外展和健康差距办公室组织。总之,我们的合作 CREP将建立必要的关键基础设施,以支持长期持续的努力, 在癌症研究中,为UR受训人员提供渠道,并支持在机构中提交未来的培训补助金 在受训人员一级提供研究金/职业发展补助金。
英文摘要
! PROJECT SUMMARY (CREP) The overall goal of the collaborative cancer research education program (CREP) between University of Houston (UH) and the NCI-designated Dan L. Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) is to encourage and prepare underrepresented (UR) undergraduate and graduate students to enter careers in cancer research. We propose to provide cancer research experiences, develop new cancer-specific curricula, and create educational outreach efforts to UR students through independent, yet complementary aims. While the overall P20 collaboration will be between UH College of Pharmacy (UHCOP) and DLDCCC, the collaborative CREP will engage undergraduate students at UH and graduate students conducting cancer research at UH and BCM. First, we will enhance the cancer research experience of undergraduate and graduate students. This will be done by (1) providing UH undergraduate students with research experience in the area of cancer drug discovery and development at both UH and DLDCCC, (2) providing access to core research facilities in a cross-institutional manner and by shared membership of thesis committee to augment the research capabilities and exposure of the graduate students at UH and DLDCCC, and (3) utilizing myNRMN and mentoring modules developed by National Research Mentoring Network (NRMN) for research mentors to effectively address cultural diversity matters in research mentoring relationships. Second, we will develop new cancer research curricula and methods for undergraduate and graduate students. Here, we will develop a multi-disciplinary seminar series on cancer research to expose UH undergraduate students to multiple areas of cancer research and a new joint course on “emerging technologies in cancer drug discovery/development” that will significantly contribute to the existing curriculum of graduate students at both UH and DLDCCC/BCM. Third, we will prepare culturally diverse health disparity aware cancer researchers. This will be done by enhancing access of UR students to mentoring and career development activities such as a newly created “Lunch with Cancer Researchers” series featuring other UR cancer researchers in various stages of their career, a GRE prep course for undergraduates, and professional development workshop on grant/fellowship development for graduate students. To increase awareness of cancer health disparities, we will also launch a new seminar series on cancer health disparities at DLDCCC and provide community outreach opportunities for CREP participants through engagement in Theater Outreach Program organized by the Office out Outreach and Health Disparity at DLDCCC. In summary, our collaborative CREP will establish the critical infrastructure needed to support a long-term sustained effort for increasing the pipeline of UR trainees in cancer research and also to bolster submission of future training grants at institution level and fellowship/career development grants at the trainee level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting and targeting oncogenic functions of PAK4 in high-risk rhabdomyosarcoma
  • 批准号:
    10577174
  • 项目类别:
  • 资助金额:
    $37.14万
  • 财政年份:
    2022
  • 负责人:
    Jason Yustein
  • 依托单位:
Cancer Research Education Program
  • 批准号:
    9789849
  • 项目类别:
  • 资助金额:
    $5.81万
  • 财政年份:
    --
  • 负责人:
    Jason Yustein
  • 依托单位:
海外基金